Ann: ResApp Builds European Market Presence, page-52

Hi fat I see where your concern lies so I called management and got a hold of Tony apparently they do not have to compare the accuracy of ResAppDx-EU it's something that our company opted to do to collect further data. Tony believes that with the team in Europe and the team here in Australia they believe they are more than capable of conducting these studies. It's all about efficacy the study will be completed quite quickly in my opinion probably within a couple of months. With the amount of patients going in through the European hospitals that have likely case of COVID-19 the extra data collection is gold as I believe the company will be able to distinguish a unique coughing signature separating this cough from all of the other ailments. This study could be a lot bigger than we think IMO

https://www.mirror.co.uk/tv/tv-news/what-coronavirus-cough-sound-like-21714542

Cheers

Red bar